Mast cells are thought to participate in a wide variety of pathophysiological conditions. Mechanisms of regulation, however, of mast cell production and maturation are still to be elucidated. Mast cell developmental process is likely to be profoundly affected by Taken together, signaling through Notch2 determines the fate of myeloid progenitors toward mast cell-producing progenitors, via coordinately upregulating Hes-1 and GATA3.
Introduction
Mast cells are thought to participate in a wide variety of physiologic and pathologic processes
In addition to their involvement in allergic disorders and protective immune responses to parasites, mast cells are important in a broader sense in both innate and acquired immunity (1, 2) . Mast cells migrate from the bone marrow at an immature differentiation stage and complete the maturation process in the peripheral tissues under the influence of local growth and differentiation factors (2) . These environmental cues tailor the mast cell phenotype to carry out functions specific to each peripheral tissue. The main factors influencing mast cell number and phenotype include stem cell factor (SCF), which is a ligand for c-Kit, interleukin-3 (IL-3), and T helper type II (Th2) -associated cytokines, such as IL-4 and IL-9 (2) . Signal transduction through the phosphatidylinositol 3 kinase pathway, Ras-mitogen activated protein kinase pathway, Janus kinase-signal transducer and activators of transcription pathway (3), etc., in the presence of IL-3 and SCF, might coordinate the lineage-specific transcription factors, but there is a disconnect between our understanding of cytokine signaling and transcription factor regulation. The generation of mast cells has been shown to be dependent on cooperative interplay between regulatory proteins: PU.1 upregulation, GATA2 upregulation (4) , and C/EBPα downregulation (5).
Notch receptor-mediated signaling has a fundamental role in cell fate determination in a variety of animals. In the mammalian immune system, Notch signaling is involved in the commitment and differentiation of T cells, development of splenic marginal zone B cells, and differentiation and functional modulation of mature T cells (6, 7) . Questions remain, however about whether and how Notch signaling regulates immune cells other than T and B cells. To the best of our knowledge, there are only two reports describing the relationship between Notch signaling and mast cells. According to these papers, Jagged-1, a Notch ligand (8) , and Notch2 (9) , are highly expressed in mast cells.
Here we demonstrate that Notch signaling has a significant role in mast cell development.
Using Notch2-null bone marrow cells, we show that Notch2 signaling promotes cell fate determination of bone marrow progenitors toward the progenitors having mast cell differentiation capacity at the expense of those that lose it. Furthermore, we demonstrate that the coordinated regulation of two transcription factors, Ηes-1 and GATA3, determines mast cell fate under Notch signaling. Overexpression of Hes-1 in myeloid progenitors represses C/EBPα mRNA expression, in agreement with the proposal that the C/EBPα downregulation provides essential condition for mast cell development (5).
These findings suggest that Notch signaling, a key regulator of lymphocytes, more broadly affects cells of the immune system through dynamic regulation of transcription factors.
Results Notch2-mediated signaling facilitates mast cell lineage development at the expense of granulocyte/macrophage development from both CMPs and GMPs in vitro
We cultured isolated CMPs and GMPs in SCF, IL-3, IL-6, and TPO for 7 d with plate-fixed Delta1-Fc chimeric protein, a soluble Notch ligand. In the culture using control Fc protein, instead of Delta1-Fc, the vast majority of the cells were Gr1 (Fig. 1A) . The cell number was not significantly different in the culture with Delta1-Fc from the culture with the control Fc protein on day 7, when the flowcytometric analysis was performed (Fig. 1B) . As shown, time courses of cell growth were different between the cultures with Delta1-Fc and control, due to the difference in the differentiation fate. Morphological observation confirmed the conversion from granulocytes/macrophages with the control Fc to mast cells, which contained toluidine blue-positive granules, with Delta1-Fc (Fig. 1C) . The expression level of mast cell-specific protease, mast cell protease-5 (mMCP5), was higher in Delta1-stimulted population compared with control (Fig. 1D ).
While all of Notch1, Notch2 and Notch3 are expressed in myeloid progenitors (Fig. 2A) . To investigate whether Hes-1 is a downstream effector of Notch signaling for mast cell enrichment by Delta1-Fc, we retrovirally expressed Hes-1 in CMPs and GMPs. Expression of the Hes-1 protein was confirmed by a western blot analysis of the retrovirally infected NIH-3T3 cells (Fig. 2B) 
GATA3, but not GATA2, is a mediator downstream of Notch2 for mast cell developmental decision, together with Hes-1
Among the GATA family of transcription factors, GATA2, which is upregulated during Notch-mediated inhibition of granulocytic differentiation (12, 13) , is proposed to be a regulator of mast cell differentiation (4, 5, 14) . Nevertheless, GATA2 expression levels in CMPs or GMPs stimulated with Delta1-Fc were equal to or lower than those stimulated with control Fc protein during the first 48 h (Fig. 3A) . GATA3 is a crucial transcription factor during T cell development. Recently, it was reported that its overexpression in double negative (DN) 1 and DN2 stage thymocytes blocked further T cell development, and unexpectedly, induced mast cells from these early thymocyte populations (15) . Physiologic relevance between GATA3 and mast cell generation, however, is yet to be elucidated. Delta1-Fc stimulation of CMPs and GMPs substantially increased GATA3 mRNA during a relatively later time course (Fig.  3B ). This finding suggests that GATA3 is a possible target of Notch signaling, albeit indirect, for mast cell production.
Thus, we examined whether Hes-1 and GATA3 are bona fide effectors functioning downstream of Notch signaling for mast cell production, by retrovirally transducing CMPs and GMPs with these genes (Fig, 3C and D). Both CMP-and GMP-derived fractions expressing Hes-1 alone (with the NGFR marker) gave rise to populations very similar to those derived from the fraction expressing Hes-1 with the GFP marker (Fig. 2C, 3C , and 3D).
There was no consistent increase in the c-Kit In contrast to these, the c-Kit When plated in methylcellulose after the retroviral infection, Hes-1-and GATA3-co-expressing CMPs and GMPs formed large and monotonous cell-containing colonies (plating efficiency, ~20% in CMPs and <10% in GMPs); staining indicated that more than 80% of colonies contained mast cells, positive for toluidine blue, as the major population ( Fig. 3 E, F , and G), while the plating efficiency was comparable to that with mock introduction (Fig. 3E ).
These observations indicate that the simultaneous expression of GATA3 and Hes-1 biased the cell fate of myeloid progenitors toward the downstream progenitors having mast cell-generating capacity at the single cell level, rather than that those transcription factors expanded the pool of mast cell progenitors or mast cells.
Hes-1 upregulation causes C/EBPα downregulation C/EBPα is a critical transcription
factor for myeloid differentiation (16) , and its downregulation cooperates with the upregulation of a GATA transcription factor to instruct mast cell development (5) . At 48 h after the initiation of Hes-1 retroviral transduction, C/EBPα mRNA was downregulated in both CMPs and GMPs (Fig. 4A ). The C/EBPα mRNA level was also markedly suppressed in a mouse myeloid cell line 32D that stably expressed exogenous Hes-1 (Fig. 4B ). These findings suggest that the C/EBPα downregulation is the major outcome of Hes-1 upregulation induced by Delta1-Notch2 signaling in the myeloid progenitors.
Discussion
In the present study, we demonstrate that Notch2-mediated signaling has a significant role in the mast cell derivation from myeloid progenitors such as CMPs and GMPs. This biological effect is probably mediated through coordinated upregulation of Hes-1 and GATA3 through We identified GATA3, not GATA2, upregulation that complements Hes-1 upregulation and creates a part of Notch signaling. Involvement of GATA2 is proposed to be important for inhibiting granulocytic differentiation downstream of Notch signaling in both the 32D cell line (13) and mouse hematopoietic progenitor cells (12) . Furthermore, GATA2 is required for in vitro mast cell generation (4, 14) , and enforced expression of GATA2 instructs the C/EBPα-deficient myeloid progenitors as well as common lymphoid progenitors to become mast cells in vitro (5). Our conclusion might appear to be inconsistent with these lines of papers. We confirmed that the enforced GATA2 and Hes-1 co-expression in CMPs and GMPs resulted in predominant mast cell generation in a manner indistinguishable from that of GATA3 and Hes-1 co-expression (data not shown). This indicates that GATA2 and GATA3 have redundant properties when they are expressed exogenously. The result of colony formation assay from CMPs and GMPs with enforced GATA3 and Hes-1 expression indicates that the mast cell derivation is based on the cell fate alteration made in the individual progenitor cells. Because the biological readout for Notch ligand stimulation was virtually the same as that for the GATA3 and Hes-1 co-expression, the substantial mast cell generation at day 7 with Delta1-Fc is likely to be mainly caused by biased cell fate decision in the myeloid progenitors.
In a different line, the introduction of GATA3 alone to thymocytes was recently reported to result in mast cell generation (15) . Although this report might appear to be inconsistent with our data, the difference in the starting cell populations could cause the different results. We conclude that the Hes-1 expression, and probably subsequent C/EBPα downregulation, is required, though not sufficient, for mast cell generation from CMPs and GMPs. In contrast, C/EBPα is already downregulated in thymocytes at the DN1 and DN2 stages (18) , and thus, introduction of GATA3 might be sufficient for mast cell generation from early thymocytes.
As for the relationship between GATA3 and Notch signaling, both Notch1 and Notch2 are important for the generation of Th2 cells, and act by directly inducing transcription of GATA3 and IL-4 (19, 20) It is, however, unclear whether such a direct regulation is applicable to cells in other lineages. In our observation, GATA3 was upregulated by Delta1-Fc at 48 h but not at 8 h in CMPs and GMPs, making it obscure whether GATA3 is a direct target of Notch signaling in these cells, while the role of IL-4 in the regulation of GATA3 remains to be determined.
We and others previously reported that enforced expression of Hes-1 in a 32D cell line inhibits granulocytic differentiation induced by granulocyte colony-stimulating factor (13, 21) . In the present study, we demonstrated that C/EBPα downregulation occurs downstream of Hes-1 in both the 32D cell line and fresh CMPs and GMPs. C/EBPα repression by Hes-1 was previously shown to be among the mechanisms of Notch-Hes-1-mediated inhibition of adipogenesis from a preadipocyte cell line (22) . Although less remarkable compared with Hes-1 overexpression, Delta1-Fc stimulation also induced C/EBPα repression, in a time course after Hes-1 upregulation. This suggests that the physiologic Hes-1 up-regulation is sufficient for C/EBPα repression (data not shown). Our data, thus, support a new paradigm that the Notch-Hes-1-C/EBPα axis consists of a common pathway for differentiation inhibition in a variety of cell lineages.
It was recently suggested that downregulation of C/EBPα followed by upregulation of a GATA factor orchestrates mast cell differentiation from myeloid progenitors (5). This could be true, but importantly, we demonstrated that such a balanced regulation of transcription factors is a result of environmental signaling through Notch2, rather than a cell-autonomous operation (Fig. 4C) . 
Materials and Methods

Mice
Notch2
flox/flox mice were described previously (10) . Mx-Cre transgenic mice (23) were 
Myeloid progenitors
Bone marrow cells from each mouse strain studied were incubated with biotinylated antibodies for lineage markers including anti-CD3, anti-CD4, anti-CD8, anti-B220, anti-Ter119, and anti-Gr-1 antibodies (BD Pharmingen) followed by incubation with streptavidin Micro Beads 
Retroviral transduction
Hes-1 cDNA, a gift from R. Kageyama, was subcloned into a retrovirus vector, GCDNsam/IRES-nerve growth factor receptor (NGFR), a gift from H. Nakauchi and M. Onodera. cDNAs for GATA3, a gift from S. Takahashi, and Hes-1 were subcloned into pMYs/IRES-GFP, a gift from T. Kitamura. A retrovirus packaging cell line, PLAT-E (26), was transfected with each retrovirus vector using FuGENE 6 (Roche Diagnostics). The conditioned medium was concentrated and placed in a 24-well non-tissue culture dish for 4 h, pre-coated with 40 μg/mL of RetroNectin (Takara Bio) overnight at 4°C. Sorted CMPs or GMPs were then plated for infection in the presence of 20% FBS, 50 ng/mL SCF, 20 ng/mL IL-3, 20 ng/mL IL-6, and 20 ng/mL TPO. Green fluorescent proteins-and/or human NGFR-positive fractions were subjected to FACS analysis 8 d after infection. Otherwise, the infected cells were sorted at 48 h from the initiation of infection with a FACSAria (Becton-Dickinson) cell sorter and used for colony assay using Methocult M3231 (StemCell Technologies), supplemented with cytokines as described above Hes-1 stably expressing 32D cell lines were previously described (13) . To confirm the protein expression, NIH-3T3 cells were also infected with the same viral supernatants using polybrene (Sigma-Aldrich).
RNA quantitation
Total cellular RNA was extracted with RNeasy (Qiagen) and converted to cDNA with Superscript III (Invitrogen). GATA2, GATA3, C/EBPα, and mouse mast cell progease-5 (mMCP-5) were analyzed with TaqMan Gene Expression assays (Applied Biosystems).
Hes-1 mRNA was measured as previously described (10) . Real-time PCR was performed using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems). All the data were standardized with the 18s ribosomal RNA.
Western blot analysis
Virus-infected NIH-3T3 cells were solubilized in lysis buffer containing 1% Triton X-100.
The Hes-1 and GATA3 proteins were detected by anti-Hes-1 antibody (H-140, Santa Cruz) and anti-GATA3 antibody (HG3-31), respectively.
Statistical analysis
Results from two or three independent experiments (n=2) of quantitative real-time PCR were analyzed by the Mann-Whitney test. 
